Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,806 total articles
Star Bulk (SBLK) sits at a 52-week high and is trading well above its 50-day averages after what the market treated as a 'record' quarter. The fundamentals of dry-bulk are cyclical and current prices already reflect robust freight rates and a generous quarterly distribution. This trade idea proposes a tactical short - entry $31.10, stop $32.20, tar…
Block remains a convoluted story: a high-growth fintech with lumpy Bitcoin exposure and a consumer franchise that the market appears to underappreciate. This trade targets that mismatch—a mid- to long-term long in SQ that assumes modest Cash App monetization improvement and a calmer macro/crypto backdrop.
Comfort Systems USA (FIX) pulled back ~15.6% into $1,640 after a sharp sell-off. The business benefits from the AI data-center buildout, a growing backlog, and strong cash flow generation. Valuation is elevated versus history, but the company’s balance sheet and margin expansion potential provide a reasonable risk/reward for a long trade over the n…
Strategy Inc (MSTR) offers asymmetric upside if Bitcoin's rally resumes; this trade idea lays out a mid-term long with a defined entry at $124.00, a protective stop at $100.00, and a $200.00 target tied to a re-acceleration in digital-asset risk appetite and share buyback execution.
Intel recently priced a large equity raise at $95 and trades below that level. The business now has clearer capital to fund foundry capacity and AI-focused CPUs. This trade buys the gap between sentiment and potential execution while keeping tight risk controls.
Star Bulk (SBLK) is trading near $31 after a run of strong earnings, improving technical momentum and a meaningful shareholder distribution. The company's market cap (~$3.5B), reasonable valuation (PE ~11.9, PB ~1.38) and continued cash returns create a compelling mid-term long setup. Entry near $30.99 with a $36 target and $27 stop balances upside…
TTM Technologies looks mispriced: the market values it like a commodity board shop while recent results and defense/european deal flow read like a prime contractor. We lay out a position trade with specific entry, stop and target and the rationale tying bookings, margin leverage and M&A to upside — plus clear risks and a trigger checklist.
Xcel Energy ($77.30) is a regulated utility with a 3%+ yield, a $60B capex runway through 2030 and targeted 6-8% EPS growth. At current valuation (market cap ~$48B, P/E ~21.6, EV/EBITDA ~14.7) the stock offers income and steady upside if rate cases and renewable investments proceed as planned. Trade plan: enter $76.50, stop $72.50, target $86.00 on…
Olympic Steel's strategic move has changed the competitive and earnings dynamics for Ryerson (RYI). The market has yet to fully price in the odds of meaningful margin improvement and cash-flow stabilization. This trade idea outlines an actionable long with a clear entry at $18.50, a stop at $14.75, and a target of $26.00 over a mid-term horizon (45…
Loblaw Companies looks priced for perfection while secular and cyclical pressures are building. We lay out a mid-term short trade with a clear entry at $45.00, stop at $52.50 and a first target at $38.00, explaining the fundamental drivers, catalysts and the scenarios that would change our mind.
Backblaze has moved from pure backup provider to a low-cost data lake for AI workloads. Recent results and a $335M CoreWeave partnership suggest the legacy "backup drag" is easing. This is a mid-term swing trade: enter at $15.50, target $22.00, stop $13.50, horizon 45 trading days, risk medium.
Applied Optoelectronics (AAOI) has been a poster child for the AI-driven optics rally. The stock's run and a fresh $600M ATM offering on 08/24/2026 suggest the market is pricing near-perfect execution and persistent, margin-rich growth. Fundamentals tell a different story: negative free cash flow, a stretched price-to-sales multiple, and repeated e…
Gen Digital reported strong Q3 FY26 results, raised guidance and continues to convert subscription cash flow into shareholder returns. If a distribution tie-in with MoneyLion (or similar fintech partners) materializes for its Trust-Based Solutions, Gen could unlock a new, high-margin channel at a valuation that looks reasonable versus cash flow. Th…
Dianthus Therapeutics (DNTH) is a clinical-stage biotech that just experienced a sector-driven sell-off in complement/C1s names. With Phase 3 momentum, sizable recent financings and a concentrated short interest, this pullback presents a tactical long setup. Entry $108.00, stop $95.00, target $150.00 over a mid-term (45 trading days) horizon.
LyondellBasell (LYB) looks healthier than it did a year ago: cash generation is positive, leverage is manageable, and commodity fundamentals (ethylene/resins) still favor producers. The company is smaller and less generous on payout, but that conservatism improves balance-sheet optionality. We upgrade to a buy for a mid-term swing trade targeting c…
Amazon's cloud business is accelerating and the market is finally giving the stock room to rerate. AWS growth, spotty retail cycles notwithstanding, plus a massive $220 billion capex push into AI infrastructure, supports a rating upgrade to long. Trade plan: enter at $264.00, stop $250.00, target $320.00 over the next 180 trading days.
Marti Technologies (MRT) is a tech-enabled urban mobility operator in Turkiye trading at ~$180M market cap. Price action and moving averages are turning constructive, short interest has pulled back, and the stock sits well above its moving-average structure. For disciplined risk-takers, a long with a defined stop captures an asymmetric upside towar…
Embecta is a beaten-up manufacturer of insulin delivery supplies trading at a fraction of prior valuation. With positive free cash flow, a low P/E, and clear near-term operational catalysts, the stock is an asymmetric risk-reward for disciplined bottom-fishing. This trade plan lays out entry, stop, target, horizon and key risks.
CME Group is trading near $279 after a period of sideways action, but several internal growth drivers and a juicy 4% yield argue for a long trade. The business is a high-margin, cash-generative marketplace with rising activity across interest rates, FX and clearing. Valuation is full on some metrics, but earnings power and a healthy dividend provid…
Fannie Mae is trading at $6.27 with a $7.26B market cap after reporting $3.7B in Q1 2026 net income. With ongoing portfolio cleanup, credit-scoring modernization, and public commentary around an IPO roadmap, we propose a mid-term (45 trading days) long trade that captures upside as markets price in progress toward privatization.
Telix has moved from a development-stage story into a commercial-scale radiopharmaceutical company. Q2 revenue of $247M and Precision Medicine strength ($202M) underpin a thesis that execution can unlock meaningful upside. This trade idea is a disciplined long that banks on continued commercial momentum, ProstACT Phase 3 progress, and regulatory al…
ATRenew's Q2 showed the same operational pulse that drove its earlier rebound: improving margins, active supply-side throughput and expanding distribution. With a $899M market cap, a PE of 14.5 and a 2.4% cash dividend yield, the setup offers asymmetric upside into a mid-term re-rating if momentum persists. Trade plan: enter $4.10, stop $3.60, targ…
Copart (CPRT) has been sold off amid a CEO transition, an earnings miss and activism/litigation headlines. Fundamentals remain solid: strong margins, conservative balance sheet and attractive cash generation. Technical momentum and a manageable short-interest profile set up a mid-term swing trade: buy into the dip with a clear stop and an upside ta…
GE Vernova sits at the center of a structural power-equipment shortage driven by AI data center buildouts and utility underinvestment. With a $176B backlog, sold-out gas turbine capacity through 2030, and healthy free cash flow, the company looks primed to convert supply constraints into higher margins. This trade idea lays out an actionable mid-te…
Rocket Lab offers a unique combination of public liquidity, meaningful backlog, recent large defense wins and an imminent technology catalyst in Neutron's first flight. At a current market cap of roughly $40.8B and trading near $68.37, the stock is richly valued on sales but offers a clearer, tradable path to upside for public-market investors comp…
